FDA grants emergency approval to Gen-Probe's H1N1 flu test

10/30/2009 | Google

The FDA has given emergency approval to Gen-Probe's Prodesse ProFlu-ST test for H1N1 flu diagnosis. The company said the test can diagnose the disease in a minimum of three hours. The approval will last for the duration of the declared pandemic, which is scheduled to expire April 26 next year.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA